NCT06736652

Brief Summary

Aim 1: Characterize and quantify changes in operationally-relevant sensorimotor and vestibular performance as a function of gravitational load. Aim 2: Characterize and quantify changes in physiology-particularly in brain function and autonomic activation during behavioral performance-as a function of gravitational load. Aim 3: Develop a model to predict behavioral performance and neurophysiological responses under different gravitational loads based on preflight ground testing data. (Hyp1) The investigators predict a monotonic but non-linear relationship between operational performance (grappling / postural sway) and gravitational load, with larger departures from 1g leading to more impaired performance. (Hyp2) The investigators predict a similar relationship between gravity load and physiological measures, with larger departures from 1g leading to larger changes in prefrontal and vestibular cortex, and autonomic nervous system activation. (Hyp3) Ground-based challenges to the vestibular system will induce detectable postural sway and neurophysiological responses. The amplitude of these responses and/or adaptation rates to the challenges (i.e., indicators of individual "sensitivity" to such provocations) will (3a) help predict neurophysiological responses in-flight, and (3b) help predict behavioral performance in flight.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2024

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
Last Updated

December 17, 2024

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

May 30, 2024

Last Update Submit

December 13, 2024

Conditions

Keywords

partial gravitymicrogravityneurophyisologybehavioral performance

Outcome Measures

Primary Outcomes (2)

  • ROBoT-r

    Operationally-relevant track-and capture behavioral measures

    10 days

  • Postural stability

    Operationally-relevant standing balance measure

    10 days

Study Arms (1)

Main study arm

EXPERIMENTAL

All subjects perform the same activities (described in the protocol), but in different orders for counterbalancing purposes.

Other: Parabolic flight

Interventions

Preflight each individual was exposed to the 3 Other Interventions and monitored for changes in behavioral performance and neurophysiological responses. In-flight the same monitoring was conducted during partial-gravity (0.25, 0.5. 0.75g) and microgravity (\~0g).

Also known as: Galvanic vestibular stimulation, Vection, Head tilts
Main study arm

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy 30-55-year-olds
  • Willingness and ability to participate in flights without motion sickness medications.
  • Any Novespace requirements

You may not qualify if:

  • Failure to meet medical criteria and provide certification of fitness for flight to NOVESPACE (i.e., NOVESPACE Parabolic Flight Medical Aptitude Certificate) completed by their medical doctor or an Authorized Medical Examiner
  • Certain heart and lung conditions
  • Dizziness
  • Certain inner ear conditions
  • Severe motor disability or impaired bone density
  • Psychosis
  • Mental disability prohibiting emergency evacuation.
  • Epilepsy
  • Certain neurological diseases
  • Fear of heights/flying
  • Debilitating anxiety and panic attacks
  • Claustrophobia
  • Women who are pregnant
  • Certain gastrointestinal conditions
  • Those taking certain medications. An individual's overall medical fitness for flight is assessed and certified by a medical doctor or Authorized Medical Examiner.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NoveSpace

Mérignac, 33700, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 30, 2024

First Posted

December 17, 2024

Study Start

March 1, 2023

Primary Completion

June 16, 2023

Study Completion

June 16, 2023

Last Updated

December 17, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

All IPD from this project will be anonymized IPD and shared. Data will be coded with a key only available to the Principal Investigator.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will be made available by the end-date of the funded project (estimated 5/31/2026) and be retained indefinitely.
Access Criteria
Researchers will be allowed to request the data from the NLSP through their website: https://nlsp.nasa.gov/explore/page/home. NASA will be responsible for vetting requests and providing the data as requested.
More information

Locations